Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma

Ähnliche Einträge

• Immunotherapy of metastatic melanoma with interferon-α and interleukin-2: Pattern of progression in responders and patients with stable disease with or without resection of residual lesions
  von: Keilholz, Ulrich, et al.
  Veröffentlicht: (1994)
• Metastatic melanoma: immunotherapy with interferon-a and interleukin-2 and second line chemotherapy
  von: Hunstein, Werner
  Veröffentlicht: (1994)
• Prognostic factors of response to immunotherapy in metastatic melanoma
  von: Hunstein, Werner
  Veröffentlicht: (1994)
• HLA class I alleles and responsiveness of melanoma to immunotherapy with interferonalpha (IFN-α) and interleukin-2 (IL-2)
  von: Scheibenbogen, Carmen, et al.
  Veröffentlicht: (1994)
• Addition of dacarbazine or cisplatin to interferon-α/interleukin-2 in metastatic melanoma: toxicity and immunological effects
  von: Keilholz, Ulrich, et al.
  Veröffentlicht: (1995)